The biomarker advantage
HealthVerity COO Andrew Goldberg recently sat down with Quest Diagnostics’ Director, Health...
HealthVerity COO Andrew Goldberg recently sat down with Quest Diagnostics’ Director, Health...
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
Given its role at the intersection of novel real-world data and emerging technologies, HealthVerity...
HealthVerity was honored to have been chosen as the first partner in Inovalon’s newly established...
One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime, that’s one...
The use of real-world data has been gaining traction in the healthcare and life sciences...
Clinical trials are out of sync. They rarely include participants in ethnic proportion to those...
If artificial intelligence (AI) is going to remain the top news story for 2023, it has to continue...
Mental health treatment for women who are pregnant or lactating is crucial to ensure positive...
Background While the COVID-19 pandemic is behind us, the virus remains a concern that needs to be studied. In the first half of 2024 alone, over 23,000 people in the United States died of the disease. The virus also continues to evolve, with the FDA ...